Publications by authors named "Michael Stidl"

Claim this Profile
I
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Hannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, Michael Stidl, Tobias Niedrist

Ther Adv Med Oncolยท November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis